UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 486: Tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for the immunotherapy of cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.486-486

2013

Volltextzugriff (PDF)

Abstract 565: A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.565-565

2019

Volltextzugriff (PDF)

Abstract PR8: Novel tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for immunotherapy of cancer

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (1_Supplement), p.PR8-PR8

2013

Volltextzugriff (PDF)

All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages

International immunopharmacology, 2014-11, Vol.23 (1), p.8-13

2014

Volltextzugriff (PDF)

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

Medical oncology (Northwood, London, England), 2004, Vol.21 (2), p.155-166

2004

Volltextzugriff (PDF)

Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma

Expert review of anticancer therapy, 2008-10, Vol.8 (10), p.1545-1557

2008

Volltextzugriff (PDF)

Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase

Cancer research (Chicago, Ill.), 1993-08, Vol.53 (15), p.3603-3610

1993

Volltextzugriff (PDF)

CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

The Journal of immunology (1950), 2006-11, Vol.177 (10), p.7398-7405

2006

Volltextzugriff (PDF)

CD4 super(+)CD25 super(high) T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

Journal of Immunology, 2006-11, Vol.177 (10), p.7398-7405

2006

Volltextzugriff (PDF)

Characterization of add(I)(p36) in non-hodgkin lymphomas by fluorescence in situ hybridization

Genes chromosomes & cancer, 1995-05, Vol.13 (1), p.34-39

1995

Volltextzugriff (PDF)

Characterization of Two Historic Smallpox Specimens from a Czech Museum

Viruses, 2017-07, Vol.9 (8), p.200

2017

Volltextzugriff (PDF)

A comparison of Linux CAN drivers and their applications

International Symposium on Industrial Embedded System (SIES), 2010, p.18-27

2010

Volltextzugriff (PDF)

Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins

Cancer Immunology, Immunotherapy, 2004-12, Vol.53 (12), p.1085-1092

2004

Volltextzugriff (PDF)

Computational Intelligence for Multimedia Understanding: International Workshop, MUSCLE 2011, Pisa, Italy, December 13-15, 2011, Revised Selected Papers

1, 2012

Volltextzugriff (PDF)

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates

Medical oncology (Northwood, London, England), 2004-01, Vol.21 (1), p.49-52

2004

Volltextzugriff (PDF)

Current perspectives in the treatment of advanced prostate cancer

Medical oncology (Northwood, London, England), 2007-09, Vol.24 (3), p.273-286

2007

Volltextzugriff (PDF)

Cyclin E Overexpression in Relapsed Adult Acute Lymphoblastic Leukemias of B-Cell Lineage

Blood, 1996-04, Vol.87 (8), p.3360-3367

1996

Volltextzugriff (PDF)

Cytokines in immune response and hematopoiesis

Pisa, Pavel

1992

Volltextzugriff (PDF)

Design-by-Optimization and Control of Redundantly Actuated Parallel Kinematics Sliding Star

Multibody system dynamics, 2005-11, Vol.14 (3-4), p.251-267

2005

Volltextzugriff (PDF)

Development of a technology platform for large-scale clinical grade production of DC

Cytotherapy (Oxford, England), 2004-08, Vol.6 (4), p.363-371

2004

Volltextzugriff (PDF)

Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-05, Vol.118 (5), p.360-365

2010

Volltextzugriff (PDF)

DNA vaccination for prostate cancer

Methods in molecular biology (Clifton, N.J.), 2008, Vol.423, p.463

2008

Volltextzugriff (PDF)

DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer

Vaccine, 2013-08, Vol.31 (37), p.3843-3848

2013

Volltextzugriff (PDF)

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

Oncogene, 2000-10, Vol.19 (45), p.5123-5133

2000

Volltextzugriff (PDF)

Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation

Molecular therapy, 2006-02, Vol.13 (2), p.320-327

2006

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 486: Tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for the immunotherapy of cancer

Abstract 565: A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors

Abstract PR8: Novel tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for immunotherapy of cancer

All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma

Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase

CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

CD4 super(+)CD25 super(high) T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

Characterization of add(I)(p36) in non-hodgkin lymphomas by fluorescence in situ hybridization

Characterization of Two Historic Smallpox Specimens from a Czech Museum

A comparison of Linux CAN drivers and their applications

Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins

Computational Intelligence for Multimedia Understanding: International Workshop, MUSCLE 2011, Pisa, Italy, December 13-15, 2011, Revised Selected Papers

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates

Current perspectives in the treatment of advanced prostate cancer

Cyclin E Overexpression in Relapsed Adult Acute Lymphoblastic Leukemias of B-Cell Lineage

Cytokines in immune response and hematopoiesis

Design-by-Optimization and Control of Redundantly Actuated Parallel Kinematics Sliding Star

Development of a technology platform for large-scale clinical grade production of DC

Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue

DNA vaccination for prostate cancer

DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation

Suchergebnisse filtern